![Respiratory therapy / Chronic lower respiratory diseases / Chronic obstructive pulmonary disease / Smoking / Asthma / Spirometry / Acute exacerbation of chronic obstructive pulmonary disease / Clinical trial / Pulmonology / Medicine / Health Respiratory therapy / Chronic lower respiratory diseases / Chronic obstructive pulmonary disease / Smoking / Asthma / Spirometry / Acute exacerbation of chronic obstructive pulmonary disease / Clinical trial / Pulmonology / Medicine / Health](https://www.pdfsearch.io/img/212bfd2c4cbd25afbb6ac2d190d79dea.jpg)
| Open Document File Size: 2,14 MBShare Result on Facebook
City Research Triangle Park / / Company GlaxoSmithKline Inc. / Clinical Laboratory / AEs / ITT / / Event FDA Phase / Product Recall / Product Issues / / IndustryTerm Treatment of Chronic Obstructive Pulmonary Disease / / MedicalCondition Asthma Studies / Pneumonia / IN COPD / Primary COPD Studies / Bone Disorders / COPD / On-Treatment Pneumonia / Pneumonias / Disorders / Asthma / / Organization FDA / Pulmonary-Allergy Drugs Advisory Committee / / Product Study / COPD / Fluticasone Furoate/Vilanterol Inhalation Powder / / ProvinceOrState North Carolina / / PublishedMedium 24 Hours / Baseline / / Technology Pharmacokinetics / Pharmacodynamics / /
SocialTag |